Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.50 +0.31 (+1.54%)
As of: Oct 22, 2026 · 10:00 AM EDT

Acadia Pharmaceuticals (ACAD) Non-Current Deffered Revenue (2010 - 2012)

Updated

Acadia Pharmaceuticals (ACAD) reported Non-Current Deffered Revenue of $2.41 million for Q2 2012, down 3.0% from $2.48 million a year earlier and down 3.8% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Non-Current Deffered Revenue (2010 - 2012) Analysis & Trends

At the end of FY2011, Acadia Pharmaceuticals posted Non-Current Deffered Revenue of $2.59 million, down 1.4% from FY2010.

  • By year, Non-Current Deffered Revenue came in at $2.62 million in FY2010.
  • Per Business Quant data, the three quarters before Q2 2012 came in at $2.5 million (Q1 2012), $2.59 million (Q4 2011) and $2.44 million (Q3 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn -
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn -
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 Acadia Pharmaceuticals 3.51 Bn 34.64 Mn 279.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 2.41 Mn
Mar 31, 2012 2.50 Mn
Dec 31, 2011 2.59 Mn
Sep 30, 2011 2.44 Mn
Jun 30, 2011 2.48 Mn
Dec 31, 2010 2.62 Mn
API Access

Acadia Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ACAD&period=max&api_key=YOUR_API_KEY